Cargando…
The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility
BACKGROUND AND AIMS: Peripheral neuropathy is a common diabetic complication. It is linked to poor glycaemic control and longer duration of diabetes. We explored the association between HbA1c and neuropathy risk considering the duration of diabetes in a sample of Saudi diabetic patients. METHOD: We...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254814/ https://www.ncbi.nlm.nih.gov/pubmed/35800515 http://dx.doi.org/10.4103/jfmpc.jfmpc_1362_21 |
_version_ | 1784740787673628672 |
---|---|
author | Alfaez, Saad M. Alsalmi, Thekra I. Alfeer, Raghad N. Alghamdi, Elaf K. Alzahrani, Mohammed Ali Al Bogami, Safar A. Mubarak, Ali S. Alshehri, Khalid M. Alfadhly, Abulaziz F. AlMalki, Basim M. Alosaimi, Jawhara A. Alzahrani, Fahad M. Al-Ghamdi, Abdullah Osman, Mugtaba |
author_facet | Alfaez, Saad M. Alsalmi, Thekra I. Alfeer, Raghad N. Alghamdi, Elaf K. Alzahrani, Mohammed Ali Al Bogami, Safar A. Mubarak, Ali S. Alshehri, Khalid M. Alfadhly, Abulaziz F. AlMalki, Basim M. Alosaimi, Jawhara A. Alzahrani, Fahad M. Al-Ghamdi, Abdullah Osman, Mugtaba |
author_sort | Alfaez, Saad M. |
collection | PubMed |
description | BACKGROUND AND AIMS: Peripheral neuropathy is a common diabetic complication. It is linked to poor glycaemic control and longer duration of diabetes. We explored the association between HbA1c and neuropathy risk considering the duration of diabetes in a sample of Saudi diabetic patients. METHOD: We conducted a monofilament test on 343 diabetic patients referred to our specialist diabetology centre in Saudi Arabia. We utilized a multiple generalized logistic regression model with a binary outcome related to neuropathy complications. RESULTS: We found that over four out of every five patients have peripheral neuropathy. The interaction between HbA1c and duration was significant (estimate = −0.02802, P = 0.00534), a positive association between neuropathy and both HbA1c (increased risk by 46.2%, P = 0.03222) and DM duration (increased risk by 19.6%, P = 0.04497). CONCLUSIONS: The shorter the duration of diabetes, the more positive the relationship between HbA1c and peripheral neuropathy. In patients living for over 40 years with diabetes, HbA1c was higher among those who did not have peripheral neuropathy. It could be argued that this is an artefact of survival as poorer glycaemic control will likely result in higher mortality in earlier years of the diabetes career. |
format | Online Article Text |
id | pubmed-9254814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-92548142022-07-06 The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility Alfaez, Saad M. Alsalmi, Thekra I. Alfeer, Raghad N. Alghamdi, Elaf K. Alzahrani, Mohammed Ali Al Bogami, Safar A. Mubarak, Ali S. Alshehri, Khalid M. Alfadhly, Abulaziz F. AlMalki, Basim M. Alosaimi, Jawhara A. Alzahrani, Fahad M. Al-Ghamdi, Abdullah Osman, Mugtaba J Family Med Prim Care Original Article BACKGROUND AND AIMS: Peripheral neuropathy is a common diabetic complication. It is linked to poor glycaemic control and longer duration of diabetes. We explored the association between HbA1c and neuropathy risk considering the duration of diabetes in a sample of Saudi diabetic patients. METHOD: We conducted a monofilament test on 343 diabetic patients referred to our specialist diabetology centre in Saudi Arabia. We utilized a multiple generalized logistic regression model with a binary outcome related to neuropathy complications. RESULTS: We found that over four out of every five patients have peripheral neuropathy. The interaction between HbA1c and duration was significant (estimate = −0.02802, P = 0.00534), a positive association between neuropathy and both HbA1c (increased risk by 46.2%, P = 0.03222) and DM duration (increased risk by 19.6%, P = 0.04497). CONCLUSIONS: The shorter the duration of diabetes, the more positive the relationship between HbA1c and peripheral neuropathy. In patients living for over 40 years with diabetes, HbA1c was higher among those who did not have peripheral neuropathy. It could be argued that this is an artefact of survival as poorer glycaemic control will likely result in higher mortality in earlier years of the diabetes career. Wolters Kluwer - Medknow 2022-05 2022-05-14 /pmc/articles/PMC9254814/ /pubmed/35800515 http://dx.doi.org/10.4103/jfmpc.jfmpc_1362_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Alfaez, Saad M. Alsalmi, Thekra I. Alfeer, Raghad N. Alghamdi, Elaf K. Alzahrani, Mohammed Ali Al Bogami, Safar A. Mubarak, Ali S. Alshehri, Khalid M. Alfadhly, Abulaziz F. AlMalki, Basim M. Alosaimi, Jawhara A. Alzahrani, Fahad M. Al-Ghamdi, Abdullah Osman, Mugtaba The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility |
title | The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility |
title_full | The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility |
title_fullStr | The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility |
title_full_unstemmed | The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility |
title_short | The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility |
title_sort | changeable dynamics between glycaemic control and neuropathy risk across the lifespan of saudi diabetic patients; a survey in diabetes healthcare facility |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254814/ https://www.ncbi.nlm.nih.gov/pubmed/35800515 http://dx.doi.org/10.4103/jfmpc.jfmpc_1362_21 |
work_keys_str_mv | AT alfaezsaadm thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alsalmithekrai thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alfeerraghadn thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alghamdielafk thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alzahranimohammedali thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT albogamisafara thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT mubarakalis thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alshehrikhalidm thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alfadhlyabulazizf thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT almalkibasimm thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alosaimijawharaa thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alzahranifahadm thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alghamdiabdullah thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT osmanmugtaba thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alfaezsaadm changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alsalmithekrai changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alfeerraghadn changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alghamdielafk changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alzahranimohammedali changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT albogamisafara changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT mubarakalis changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alshehrikhalidm changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alfadhlyabulazizf changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT almalkibasimm changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alosaimijawharaa changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alzahranifahadm changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT alghamdiabdullah changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility AT osmanmugtaba changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility |